Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
Association between non-alcoholic fatty liver disease and cancer incidence rate.
CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
Prognostic Scoring Models for Patients Undergoing Sorafenib Treatment for Advanced Stage Hepatocellular Carcinoma in Real-Life Practice.
Role of Computed Tomography Volumetry in Estimating Liver Weights in Surgical Patients with Hepatic Steatosis.
Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells.
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study.
Clinical characteristics and potential etiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic areas.
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.
Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma.
Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.
Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Response to Letter Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study".
Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.
Association between flavonoid intake and diabetes risk among the Koreans.
Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.
Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma.
Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
Prevalence analysis of de novo hepatic steatosis following pylorus-preserving pancreaticoduodenectomy.
Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
Reappraisal of serum alpha-foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
Clinical Implications of Arrest-Defective Protein 1 Expression in Hepatocellular Carcinoma: A Novel Predictor of Microvascular Invasion
Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients.
Clinical utility of des-γ-carboxyprothrombin kinetics as a complement to radiologic response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Effect of Response to Interferon-alpha Therapy on the Occurrence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Exercise and diet modification in non-obese non-alcoholic fatty liver disease: Analysis of biopsies of living liver donors
Half-Life of Serum Alpha-Fetoprotein: An Early Prognostic Index of Recurrence and Survival After Hepatic Resection for Hepatocellular Carcinoma.
High HBV-DNA Titer in Surrounding Liver Rather Than in Hepatocellular Carcinoma Tissue Predisposes to Recurrence After Curative Surgical Resection
Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis
Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma
Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes
Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma
Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma
Which response criteria best help predict survival of patients with hepatocellular caricnoma following chemoembolization? A validation study of old and new models.
Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center.
Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?
Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?
Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in hepatitis B virus-endemic area.
Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.
Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinations.
C형간염바이러스 유전자형 1b에 감염된 한국인 환자에서 인터페론 감수성 결정 영역의 유전자 돌연변이 양상
중증 간질환을 동반한 적혈구조혈성 포르피린증 환자에서의 cholestyramine 치료: 사례보고
Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection.
Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation.
Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
Percutaneous management of a bronchobiliary fistula after radiofrequency ablation in a patient with hepatocellular carcinoma.
Surgical Treatments and Prognoses of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis
Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay,restriction fragment mass polymorphism.
특발성 비신단락을 동반한 간경변증 환자의 간성 척수병증 2예
Biochemical Rather than Virologic Response to Interferon Therapy may be More Closely Associated with Decrease of Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B
Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors.
Increased risk of adeforvir resistance in patients with lamivudine-resistant chronic heapatitis B after 48 weeks of adfovir dipivoxil monotherapy
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
진행된 간세포암에서의 간문맥 혈전증에 대한 방사선치료 효과
Association of specific amino acid sequence of HLA-DR with autoimmune hepatitis
Clinical Features And Outcomes of Hepatic Failure Assoiciated with Epstein-Barr Virus lnfection
Clinical Features And Outcomes of Severe Epstein-Barr Virus Hepatitis Presented with Jaundice
Clinical Features of Fulminant Hepatic Failure in a Tertiary Hospital with a Liver Transplant Center in Korea
Eupatilin attenuates bile acid-induced hepatocyte apoptosis.
Increased risk of adefovir resistance in patients with Iamivudine-resistant chronic hepatitis B after 48 weeks of adfovir dipivoxil monotherapy
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
Nine Cases of Sporadic Acute Hepatitis E in Korea
Safety and Efficacy of Three-Dimensional Conformal Radiotherapy for Portal Vein Tumor Thrombus by Hepatocellular Carcinoma
간세포암의 문맥 침범에 대한 방사선치료의 효과와 안전성
A형 간염 바이러스에 의한 전격성 간부전 5예의 임상 경과
간세포암의 하대정맥 침범에 대한 방사선치료의 효과
Adefovir dipivoxil alone or in combination with ongoning lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus
전격성 간부전의 원인, 임상양상, 사망예견인자
한국 성인 자가 면역성 간염 환자들에서 감수성 조직적합항원(HLA) 분석